Best Startup
At Best Startup UK we track over 130,000 UK startups and over 500,000 people who hold key positions in these companies. We use this directory of startups to highlight top employees, founders and board members we think deserve more appreciation than they are currently getting.
This list showcases the top United Kingdom based Executive Director operating in the Health Diagnostics space. If you think a Executive Director is missing from this list, feel free to contact our editor on editor@beststartup.co.uk.
The individuals on this list have been included because of exceptional performance in one of the following categories:
- Innovation – Operating as a key part in an extremely innovative business or startup.
- Growth – Operating as a key figure in the growth and upscale of a market leading business or startup.
- Management – Showing exceptional management skills.
- Societal impact – Putting their business on the map for their positive societal or environmental impact.
Our Data – We source our data from OSINT (open source intelligence) and public directories such as Companies House UK, Crunchbase, SemRush and many more. The data from these sources should be treated with a degree of caution and verified yourself.
John Clarkson
Non Executive Director of Binx Health
John Clarkson has been in healthcare and diagnostics businesses for the past 15 years and has a background in molecular biology. He co-founded Molecular Sensing plc in 1999 where he was Commercial Director and then Technical Director. Following the successful development of their DNA analysis system, he joined the US-based diagnostics company Osmetech plc when they acquired Molecular in 2004. John led the formation of Atlas Genetics in 2005 as a joint spin-out from the University of Bath and Osmetech plc. Atlas is developing rapid tests for infectious diseases such as the sexually transmitted infections Chlamydia and gonorrhea, and hospital acquired infections. The company is VC backed and raised £18.5m in 2011 in a series B financing round led by Novartis Venture Funds.
Follow John Clarkson:
About Binx Health: Binx Health creates new categories of healthcare solutions that deliver on-demand testing to people where they need it most.
Susan Searle
Non-Executive Director of Horizon Discovery
Susan Searle is Chief Executive Officer of Imperial Innovations Group plc, an AIM listed company founded by Imperial College. Imperial Innovations is an integrated business combining the activities of technology transfer, incubation and investment across healthcare, engineering, environment and IT sectors. Susan has been instrumental in growing the business since joining the Ltd company in 1994. Previously she worked at Montech (Australia), Signet Group plc, Bank of Nova Scotia and Shell Chemicals Limited in the UK and internationally in a variety of business development and commercial roles. She has served on the boards of 15 spin-out companies including TurboGenset Inc. and sits on the boards of Thiakis Limited, EVO Electric Limited and i2india Holdings Limited. She has an MA in Chemistry from Exeter College, Oxford University.
Follow Susan Searle:
About : Horizon is a gene editing company that designs & engineers genetically-modified cells, applying them to advance human health.
Charles Hindson
Non Executive Director of Diaceutics
Follow Charles Hindson:
About Diaceutics: Diaceutics Group leverages analytics, software, services and consulting.
Alan Boyd
Non-Executive Director of Linear Diagnostics
Prof. Alan Boyd – Advisory Board – CEO Boyd Consultants, Past President of Faculty of Pharmaceutical Medicine, Former Head of Medical Research for Zeneca – track record of bringing medical developments to market.
Follow Alan Boyd:
About Linear Diagnostics: Linear Diagnostics Limited is a diagnostics company based on a novel technology
Paul Bailey
Non-Executive Director of Bailey Fisher Executive Search
Paul co-founded Bailey Fisher Executive Search in 1998 and led the growth of the business as Managing Director for 20 years during which time he built the board and management teams for some of the most innovative companies to have emerged from the European technology market. After a successful exit in July 2018, he took on the role of Executive Chairman. Paul was named in the 2016 Maserati 100 and was recognised as one of the most influential business people in Cambridge in 2017. He has held advisory roles with NESTA Impact Investments and New Wave Ventures. Paul joined Martlet Capital in 2019. He is also currently Entrepreneur in Residence at Cambridge Enterprise.
Follow Paul Bailey:
About : Bailey Fisher is an independent executive search firm finding & attracting individuals who have a fundamental impact on business growth.
